Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
When immunotherapy hurts: neoadjuvant PD-1 inhibitors increase opioid use after mastectomy with reconstruction.
Journal: Breast cancer research and treatment
Published: July 07, 2026
Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 17, 2026
Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications.
Journal: Cancer cell
Published: April 22, 2025
Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates.
Journal: bioRxiv : the preprint server for biology
Published: April 16, 2025
Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes.
Journal: Breast cancer research and treatment
Published: February 06, 2025
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysis.
Journal: NPJ breast cancer
Published: November 18, 2024
Novel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child.
Journal: Expert review of anticancer therapy
Published: April 20, 2024
Targeting the Androgen Signaling Axis in Prostate Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 10, 2023
Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis.
Journal: JCO precision oncology
Published: May 04, 2023
Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis.
Journal: Breast cancer research : BCR
Published: January 17, 2023
Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 08, 2022
Last Updated: 09/26/2026